2026年11月3日星期二
M
Rekod Semesta
Berita Pantas Global
Working collaboratively to fight scams in Asia Pacific— Google 官方博客Why PC makers are turning back to China— 日经 Nikkei AsiaAustralia gold miner Northern Star lifts output amid investor pressure— 日经 Nikkei AsiaMalaysia transport minister still plans to quit, says megaprojects safe— 日经 Nikkei AsiaApple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaJapan's Aisin develops new type of AI chip that cuts energy use 98%— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaWorking collaboratively to fight scams in Asia Pacific— Google 官方博客Why PC makers are turning back to China— 日经 Nikkei AsiaAustralia gold miner Northern Star lifts output amid investor pressure— 日经 Nikkei AsiaMalaysia transport minister still plans to quit, says megaprojects safe— 日经 Nikkei AsiaApple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaJapan's Aisin develops new type of AI chip that cuts energy use 98%— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei Asia

Emerging role of LncRNAs MMP2-AS1, FAM222A-AS1, and XIST as potential biomarkers in HIV patients receiving antiretroviral therapy

Sumber Nature 生命科学7 hari lalu
Ringkasan kandungan

Laman ini hanya menyediakan indeks tajuk dan ringkasan, kandungan penuh dan hak cipta adalah milik pihak penerbit asal, sila klik pautan asal untuk membaca.

Pergi ke artikel asal
Saluran berkaitan
Sains
Kawasan berkaitan
Perspektif global
Bahasa teks asal
English
Nombor entri
science-15d86306

Comments 0 comments

No comments yet. Be the first.

Emerging role of LncRNAs MMP2-AS1, FAM222A-AS1, and XIST as potential biomarkers in HIV patients receiving antiretroviral therapy · Rekod Semesta